XML 27 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jan. 02, 2021   7,693,497    
Beginning balance at Jan. 02, 2021 $ 209,019 $ 503 $ 216,999 $ (8,483)
Increase (Decrease) in Shareholders' Equity        
Net income 41,679   41,679  
Foreign currency translation adjustment (1,467)     (1,467)
Issuance of restricted common stock for contingent consideration (in shares)   40,039    
Issuance of restricted common stock for contingent consideration 2,250 $ 2,250    
Exercise of stock options (in shares)   192,803    
Exercise of stock options 5,157 $ 5,157    
Share-based compensation expense 4,086 $ 4,086    
Restricted shares vesting (in shares)   65,242    
Redemption of vested employee restricted shares for tax withholding (in shares)   (20,133)    
Redemption of vested employee restricted shares for tax withholding (1,528) $ (1,528)    
Shares repurchased (in shares)   (608,745)    
Shares repurchased (44,976) $ (10,468) (34,508)  
Accrued dividends on unvested shares (97)   (97)  
Cash dividends paid to shareholders (8,289)   (8,289)  
Ending balance (in shares) at Jan. 01, 2022   7,362,703    
Ending balance at Jan. 01, 2022 205,834 $ 0 215,784 (9,950)
Increase (Decrease) in Shareholders' Equity        
Net income 43,619   43,619  
Foreign currency translation adjustment (5,031)     (5,031)
Issuance of restricted common stock for contingent consideration 0      
Exercise of stock options (in shares)   61,645    
Exercise of stock options 1,411 $ 1,411    
Share-based compensation expense 4,773 $ 4,773    
Restricted shares vesting (in shares)   66,127    
Redemption of vested employee restricted shares for tax withholding (in shares)   (21,057)    
Redemption of vested employee restricted shares for tax withholding (2,145) $ (2,145)    
Shares repurchased (in shares)   (319,534)    
Shares repurchased (27,630) $ (2,296) (25,334)  
Accrued dividends on unvested shares (97)   (97)  
Cash dividends paid to shareholders $ (9,580)   (9,580)  
Ending balance (in shares) at Dec. 31, 2022 7,149,884 7,149,884    
Ending balance at Dec. 31, 2022 $ 211,154 $ 1,743 224,392 (14,981)
Increase (Decrease) in Shareholders' Equity        
Net income 38,481   38,481  
Foreign currency translation adjustment 2,799     2,799
Issuance of restricted common stock for contingent consideration 0      
Exercise of stock options (in shares)   26,000    
Exercise of stock options 805 $ 805    
Share-based compensation expense 4,400 $ 4,400    
Restricted shares vesting (in shares)   83,158    
Redemption of vested employee restricted shares for tax withholding (in shares)   (28,619)    
Redemption of vested employee restricted shares for tax withholding (3,063) $ (3,063)    
Shares repurchased (in shares)   (296,158)    
Shares repurchased (31,417) $ (3,885) (27,532)  
Accrued excise tax on shares repurchased (247)   (247)  
Accrued dividends on unvested shares (4)   (4)  
Cash dividends paid to shareholders $ (10,807)   (10,807)  
Ending balance (in shares) at Dec. 30, 2023 6,934,265 6,934,265    
Ending balance at Dec. 30, 2023 $ 212,101 $ 0 $ 224,283 $ (12,182)